Biotechnology

DESIGNED IN PHILADELPHIA. MADE IN USA. SHIPPED WORLDWIDE. Founded in Philadelphia in 2015 by an immigrant biomedical researcher, AUM BioTech now designs the precision compounds that scientists in nearly forty countries use to study how genes function, and understand what goes wrong in disease. In 2009, Veenu Aishwarya arrived in Philadelphia from India to train

In Maryland, scientific discovery rarely slows progress. Laboratories across the state generate breakthrough therapeutics, diagnostics, and medical technologies at remarkable speed. Moving those innovations beyond the lab and into the hands of patients and investors requires a different kind of expertise, grounded in market insight, capital strategy, and disciplined execution. BioHealth Innovation was created to

Conversations about innovation happen constantly, yet execution rarely receives the same attention. Breakthrough research can capture headlines, attract investment, and signal scientific progress, yet discovery alone rarely builds industries or creates lasting economic growth. The hard work continues after the breakthrough, when ideas must leave the laboratory and prove themselves in the real world. Researchers

The Brock Family Center for Applied Innovation was established at Vanderbilt University Medical Center in 2023 through a $10 million gift from the Brock family, including John F. Brock III, his wife, Mary, and their three adult children – Rebecca Brock Dixon, John F. Brock IV and Major Brock. The Brock family has supported the

In Estonia, where wood has shaped livelihoods for centuries, one company is reimagining its potential for the next industrial era. Fibenol is transforming undervalued hardwood and plywood industry residues into high-purity biomaterials that offer sustainable alternatives to fossil-based inputs. Its mission is both simple and bold: To help industries defossilize their value chains and accelerate

Some of the most meaningful innovations don’t begin with a grand plan. They begin when you hit a wall. A few years ago, we were developing a new therapeutic antibody. To really understand it, we had to figure out where it grabbed onto its target molecule—and what happened to that target once the antibody latched

In the heart of Sweden’s thriving life sciences ecosystem, a young biotechnology company is redefining how the world understands and engineers therapeutic antibodies. Founded by researchers from the prestigious Karolinska Institutet, AAX Biotech is on a mission to transform antibody-based medicine—turning scientific breakthroughs into next-generation therapies for some of the world’s most challenging diseases. Science-driven,

Life Sciences Nova Scotia (LSNS) is more than just an organization; it is the cornerstone of Nova Scotia’s life sciences community, fostering growth, innovation, and collaboration across the province and Atlantic Canada. At its core, LSNS is driven by the belief that transformative ideas in biotechnology, healthcare, and pharmaceuticals can improve lives and generate lasting

As the CEO of Life Sciences Nova Scotia, I have the privilege of witnessing firsthand the creativity, resilience, and vision of the people and companies driving change in the life sciences sector. From pioneering healthcare solutions to cutting-edge biotechnology developments, the Atlantic region is making a profound impact both locally and globally. This book is

Sightera Biosciences accelerates drug discovery with an innovative approach that combines chemical structure analysis with complex patient-relevant preclinical models to design novel therapies. Due to the organization’s exclusive research collaboration with the DrugVision.AI screening platform of the University of Antwerp/UZA, it can produce exclusive datasets from patient-derived models to train its AI-driven engine, focusing on